Seven Fleet Capital Management’s Astria Therapeutics ATXS Stock Holding History

Seven Fleet Capital Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,000	Closed	-$52.4K	–	118
2025 Q4	$52.4K	Buy	+4,000	New	+$47.8K	0.04%	78

Seven Fleet Capital Management's ATXS Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 4,000 shares — an estimated $52.4K sold.

Seven Fleet Capital Management first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $52.4K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Seven Fleet Capital Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Seven Fleet Capital Management sold 4,000 Astria Therapeutics shares in Q1 2026, an estimated $52.4K.
Seven Fleet Capital Management first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Seven Fleet Capital Management's Astria Therapeutics position peaked at $52.4K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.